ID

22956

Descripción

Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study; ODM derived from: https://clinicaltrials.gov/show/NCT00539448

Link

https://clinicaltrials.gov/show/NCT00539448

Palabras clave

  1. 18/6/17 18/6/17 -
Subido en

18 de junio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 1 NCT00539448

Eligibility Diabetes Mellitus, Type 1 NCT00539448

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed type i diabetic patients
Descripción

ID.1

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C1320655
type i diabetes treated with basal-bolus regimen including 3 or more injections of regular human insulin per day
Descripción

ID.2

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C0087111
bmi, 26-40 kg/m2
Descripción

ID.3

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
hba1c, 7.5%-10%
Descripción

ID.4

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019018
median 2hrs post -prandial more than or equal to 140 mg/dl (more than or equal to 7.8 mmol/l)
Descripción

ID.5

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428554
fpg more than or equal to 120 mg/dl (more than or equal to 6.7 mmol/l)
Descripción

ID.6

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428554
willingness to accept, and ability to inject insulin glargine therapy
Descripción

ID.7

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0557978
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy : the use of lantus & apidra during pregnancy is not contraindicated. however, in the absence of supportive data, sanofi- aventis pharmaceuticals cannot specifically recommend the use of lantus in this patient population
Descripción

ID.8

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial
Descripción

ID.9

Tipo de datos

boolean

Similar models

Eligibility Diabetes Mellitus, Type 1 NCT00539448

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
newly diagnosed type i diabetic patients
boolean
C0011854 (UMLS CUI [1,1])
C1320655 (UMLS CUI [1,2])
ID.2
Item
type i diabetes treated with basal-bolus regimen including 3 or more injections of regular human insulin per day
boolean
C0011854 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
ID.3
Item
bmi, 26-40 kg/m2
boolean
C1305855 (UMLS CUI [1])
ID.4
Item
hba1c, 7.5%-10%
boolean
C0019018 (UMLS CUI [1])
ID.5
Item
median 2hrs post -prandial more than or equal to 140 mg/dl (more than or equal to 7.8 mmol/l)
boolean
C0428554 (UMLS CUI [1])
ID.6
Item
fpg more than or equal to 120 mg/dl (more than or equal to 6.7 mmol/l)
boolean
C0428554 (UMLS CUI [1])
ID.7
Item
willingness to accept, and ability to inject insulin glargine therapy
boolean
C0557978 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.8
Item
pregnancy : the use of lantus & apidra during pregnancy is not contraindicated. however, in the absence of supportive data, sanofi- aventis pharmaceuticals cannot specifically recommend the use of lantus in this patient population
boolean
C0032961 (UMLS CUI [1])
ID.9
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial